Limitations of bone formation in oral implantology : inhibition of osteoblast functions by gingival tissues

• Main Author: Al-Masri, Maher
• Published: Queen Mary, University of London 2010
• Subjects: 617.6; Dentistry
• Online Access: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.516682

Clinical observation suggest that bone formation is influenced by the environmental niche where it takes place and specifically that soft connective tissues may inhibit the bone healing process. The aim of the studies described in this thesis is to test the hypothesis that fibroblasts inhibit the differentiation and function of osteoblasts in vitro. To address this aim the ability of fibroblasts and their supernatants to inhibit osteoblast differentiation was investigated. In addition, the inhibitory effects of gingival and periodontal ligament fibroblasts were compared. Next Bone Morphogenetic Proteins (BMPs) and their antagonists were tested for their ability to modulate the activity of fibroblast supernatants. Finally the effects of fibroblast supernatants on osteoblast chemotactic responses were investigated. Primary fibroblasts were isolated from rat gingivae, skin, oral mucosa and periodontal ligament (PDL) using explant cultures. Primary osteoblast cultures were established by enzymatic digestion of neonatal rat calvariae. In other experiments the osteoblastic cell line ROS 17/2.8 was used. Osteoblast differentiation was assessed by measuring alkaline phosphatase (ALP). In co-culture experiments using 3-D collagen gels and diffusion chamber inserts fibroblasts strongly inhibited osteoblast differentiation. Furthermore conditioned medium from superficial connective tissues fibroblasts consistently inhibited osteoblast differentiation (greater than 50% inhibition of ALP expression. In contrast, PDL cells strongly stimulated ALP expression (greater than 100% increase). Stimulation of ROS 17/2.8 cells with BMP-2 increased ALP expression (more than 3 fold increase with 10ng/ml BMP-2), and this effect could be completely blocked by the BMP-antagonist 100ng/ml noggin. Similarly conditioned media from gingival, oral mucosal and skin fibroblasts totally suppressed the effects of BMP-2. In contrast, PDL conditioned media stimulated ALP expression in additively with BMP-2, and his effect could also be blocked by noggin. Using a micro-well Boyden Chamber both PDGF and BMP-2 caused a dose-dependent increase in chemotaxis. However fibroblast conditioned medium totally blocked the chemotactic effects on BMP-2, but had no effect on PDGF-induced chemotaxis. Overall these studies demonstrate that fibroblasts from superficial connective tissues (gingival, oral mucosa and skin) can inhibit osteoblast function by secretion of BMPantagonists and that superficial connective tissues and PDL are distinct in respect to their role in bone healing. Further studies are needed to identify the specific molecular identity of this inhibitory activity and to extend these observations to an in vitro model. However in the longer term it is proposed that information on the regional expression of BMP inhibitors may lead to novel therapeutic interventions to promote bone growth in periodontal and implant related bone regeneration procedures.